Comparison of effects of combined ACE inhibitor and low-dose thiazide diuretic with ACE inhibitor alone on insulin action in patients with hypertension and Type 2 diabetes: A double-blind crossover study

Diabetic Medicine

Volumn 25, Issue 5, 2008, Pages 631-634

  McLaughlin, D M ^a,c   Atkinson, A B ^a   Ennis, C N ^a   Browne, J ^b   Hunter, S J ^a   Sheridan, B ^a   Bell, P M ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b Carryduff Health Centre   (United Kingdom)

^c ULSTER HOSPITAL   (United Kingdom)

Author keywords

Bendroflumethiazide; Captopril; Hypertension; Insulin resistance

Indexed keywords

BENDROFLUMETHIAZIDE; CAPTOPRIL; GLUCOSE; INSULIN; PLACEBO;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG ANTAGONISM; DRUG DOSE INCREASE; DRUG EFFECT; DRUG MECHANISM; DRUG SAFETY; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INFUSION; GLUCOSE UTILIZATION; GLYCEMIC CONTROL; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN SENSITIVITY; LOW DRUG DOSE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BENDROFLUMETHIAZIDE; CAPTOPRIL; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPERTENSION; INSULIN; INSULIN RESISTANCE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 42549117991     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2008.02437.x     Document Type: Article

References (12)

1. ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to ACE inhibitor or calcium channel blocker vs. diuretic. The Antihypertensive and Lipid Lowering Treatment to prevent heart attack trial (ALLHAT). J Am Med Assoc 2002 288 : 2981 2997.
2. Dahlof B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M et al. for the ASCOT investigators. Prevention of cardiovascular events with an anti-hypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomized controlled trial. Lancet 2005 366 : 895 906.
3. Harper R, Ennis CN, Heaney AP, Sheridan B, Gormley M, Atkinson AB et al. A comparison of the effects of low- and conventional-dose thiazide diuretic on insulin action in hypertensive patients with NIDDM. Diabetologia 1995 38 : 853 859.
4. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr et al. The seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure: the JNC 7 report. J Am Med Assoc 2003 289 : 2560 2572.
5. Williams B, Poulter NR, Brown MJ, Davis M, McInncs GT, Potter JF et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens 2004 18 : 139 185.
6. UKPDS Group. Tight blood pressure control and risk of macrovascular and microvascular complications in Type 2 diabetes: UKPDS 38. Br Med J 1998 317 : 703 713.
7. Hunter SJ, Wiggam MI, Ennis CN, Whitehead HM, Sheridan B, Atkinson AB et al. Comparison of effects of captopril used either alone or in combination with a thiazide diuretic on insulin action in hypertensive Type 2 diabetic patients: a double-blind crossover study. Diabet Med 1999 16 : 482 487.
8. Neely RDG, Rooney DP, Atkinson AB, Sheridan B, Ennis CN, Trimble ER et al. Underestimation of glucose turnover determined using (6-3H) glucose tracer in non-steady state. The role of a titrated tracer impurity. Diabetologia 1990 33 : 681 687.
9. Hills M, Armitage P. The two-period crossover clinical trial. Br J Clin Pharmacol 1979 8 : 7 20.
10. Patel A, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L et al ADVANCE Collaborative Group, Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomized controlled trial. Lancet 2007 370 : 829 840.
11. Zanchetti A, Ruilope A. Anti-hypertensive treatment in patients with Type 2 diabetes mellitus: what guidance from recent controlled randomized trials. J Hypertens 2002 20 : 2099 2110.
12. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF et al. British Hypertension Guidelines for hypertension management 2004 (BHS-IV), summary. Br Med J 2004 328 : 634 640.